SynBiotic SE
SynBiotic SE (SBX) is a Drug manufacturers specialty generic company in the Healthcare sector, listed on Deutsche Borse Xetra. This page provides the complete earnings calendar, dividend schedule, and financial data for SynBiotic SE in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.
- Sector
- Healthcare
- Industry
- Drug manufacturers specialty generic
- Country
- Germany
- Exchange
- Deutsche Borse Xetra
- CEO
- Daniel Kruse
- Employees
- 55
- IPO date
- 07 Jan 2021
- ISIN
- DE000A3E5A59
- Website
- synbiotic.com
Frequently asked questions
Where is SynBiotic SE stock listed?
SynBiotic SE (SBX) is listed on Deutsche Borse Xetra.